Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L H Woodlief

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Controlled Clinical Trials|December 31, 1997
Developing systems for cost-effective auditing of clinical trialsR M Califf, S L Karnash, L H Woodlief
Journal of the American College of Cardiology|December 1, 1995
Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trialS L Karnash, C B Granger, H D White, et al.
Circulation|January 15, 1995
Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarctionC L Grines, E J Topol, W W O'Neill, et al.
Circulation|July 1, 1994
Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction. Final results from the Primary Angioplasty RegistryB R Brodie, C L Grines, R Ivanhoe, et al.
Journal of the American College of Cardiology|November 1, 1995
Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary ArteriesG I Barbash, J Reiner, H D White, et al.
JAMA|February 12, 1998
Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesW R Hathaway, E D Peterson, G S Wagner, et al.
Journal of the American College of Cardiology|February 1, 1997
Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesB E Tardiff, R M Califf, D Morris, et al.
Circulation|December 1, 1994
Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesN S Kleiman, H D White, E M Ohman, et al.
Circulation|March 15, 1995
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I InvestigatorsK L Lee, L H Woodlief, E J Topol, et al.
Circulation|May 1, 1993
Systolic left ventricular function after reperfusion therapy for acute myocardial infarction. Analysis of determinants of improvement. The TAMI Study GroupJ K Harrison, R M Califf, L H Woodlief, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Controlled Clinical Trials|December 31, 1997
Developing systems for cost-effective auditing of clinical trialsR M Califf, S L Karnash, L H Woodlief
Journal of the American College of Cardiology|December 1, 1995
Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trialS L Karnash, C B Granger, H D White, et al.
Circulation|January 15, 1995
Effect of cigarette smoking on outcome after thrombolytic therapy for myocardial infarctionC L Grines, E J Topol, W W O'Neill, et al.
Circulation|July 1, 1994
Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction. Final results from the Primary Angioplasty RegistryB R Brodie, C L Grines, R Ivanhoe, et al.
Journal of the American College of Cardiology|November 1, 1995
Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary ArteriesG I Barbash, J Reiner, H D White, et al.
JAMA|February 12, 1998
Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesW R Hathaway, E D Peterson, G S Wagner, et al.
Journal of the American College of Cardiology|February 1, 1997
Coronary revascularization surgery after myocardial infarction: impact of bypass surgery on survival after thrombolysis. GUSTO Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesB E Tardiff, R M Califf, D Morris, et al.
Circulation|December 1, 1994
Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary ArteriesN S Kleiman, H D White, E M Ohman, et al.
Circulation|March 15, 1995
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I InvestigatorsK L Lee, L H Woodlief, E J Topol, et al.
Circulation|May 1, 1993
Systolic left ventricular function after reperfusion therapy for acute myocardial infarction. Analysis of determinants of improvement. The TAMI Study GroupJ K Harrison, R M Califf, L H Woodlief, et al.
Pageof 2